With amyloid immunotherapy in clinical use, scientists need to find better ways to identify the patients most at risk of developing ARIA (see part 16 of this series). One of the biggest danger signs, ...

Please provide your email address to receive an email when new articles are posted on . Cerebral amyloid angiopathy was associated with a higher risk for isolated nontraumatic subdural hemorrhage in ...

What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down syndrome—one of the most robust populations for studying Alzheimer's disease ...

A 74-year-old man with an unremarkable medical history noted a progressive gait disorder in the months prior to admission. His wife recalled increased sleepiness and loss of initiative. After having ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The results of the phase 3 trial of the anti–amyloid-β drug lecanemab for the treatment of early Alzheimer’s disease, reported in the Journal by van Dyck et al., 1 have suggested a beneficial effect ...